WBA News and Press, Walgreens Boots Alliance Inc. From 05/07/24

2024-05-07 09:00:00 ET Summary Walgreens Boots Alliance faces significant business challenges and has no easy solutions. Wall Street remains skeptical about Walgreens' ability to overcome its immense challenges. I urge investors to be cautious about its so-called "cheap" valua...

2024-05-06 17:06:50 ET Summary Walgreens Boots Alliance is currently trading at a cheap valuation with a non-GAAP Fwd P/E of 5.5x. The company is an integrated healthcare and pharmacy retailer with a strong presence in the US, Europe, and Latin America. With a new CEO and a pl...

2024-05-06 13:41:08 ET Summary Walgreens Boots Alliance, a famed pharmacy retailer, is in the midst of a turnaround. In the last decade, WBA shares dropped from over $70 to less than $20. More recently, the quarterly dividend was nearly cut in half. Their new CEO has an ey...

2024-05-04 06:16:07 ET Summary CVS Health reported dismal earnings on May 1st, substantially dropping the stock price, resulting in the largest one-day drop on record. While revenues nearly met consensus expectations, current quarter EPS and forward earnings were slashed, roughly ...

2024-05-03 15:36:12 ET Summary Traditional investment strategies are no longer effective in modern markets, causing financial pain for self-directed investors and investment advisors. Indexation, algorithms, and other factors make investing more like a voting machine, rather than ...

2024-05-03 07:15:00 ET Summary Earnings season presents buying opportunities for stocks that have experienced a dip in price after reporting Q1 earnings. Enterprise Products Partners offers a 7% yield and has strong fundamentals, including a well-covered distribution and positive ...

2024-05-02 07:39:33 ET More on Walgreens Boots Alliance 3 Reasons Walgreens Can See Upside (Rating Upgrade) Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed Walgreens Post-Earnings: Jury's Still Out, Still A Lot Of Questions ...

Joint collaborations bring Boehringer Ingelheim’s Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio’s mobile research units, aimed at improving access to trials Walgreens and Boehringer Ingelheim today announced a strateg...

Walgreens (Nasdaq: WBA): UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE ACTION TO: ALL PERSONS WHO OWNED SHARES OF THE COMMON STOCK OF WALGREENS BO...

2024-05-01 13:03:51 ET More on CVS Health CVS Health Corporation (CVS) Q1 2024 Earnings Call Transcript CVS Health Corporation 2024 Q1 - Results - Earnings Call Presentation CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot Biggest stock mov...